Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
주식 순위 #830
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
주가
$71.40
시가총액
$29.93B
변동 (1일)
-0.13%
변동 (1년)
-51.06%
국가
US
거래 Zoetis Inc. (ZTS)

카테고리

Zoetis Inc. (ZTS)의 P/E 비율
September 2026 기준 P/E 비율 TTM: 12.12
Zoetis Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/E (TTM) 비율은 12.12입니다. 2023년 말 기준 P/E 비율은 38.83였습니다.
Zoetis Inc.의 P/E 비율 기록 (2009 ~ 2026)
매년 말 P/E 비율
연도 P/E 비율 변화
2026 (TTM) 12.12 -59.29%
2024 29.77 -23.34%
2023 38.83 19.46%
2022 32.51 -42.80%
2021 56.83 18.28%
2020 48.04 13.88%
2019 42.19 45.79%
2018 28.94 -29.16%
2017 40.85 26.39%
2016 32.32 -54.24%
2015 70.64 91.00%
2014 36.98 14.03%
2013 32.43 -8.80%
2012 35.56 -41.24%
2011 60.52 -55.10%
2010 134.79 -190.91%
2009 -148.27 0.00%
유사 기업 또는 경쟁사의 P/E 비율
회사 P/E 비율 P/E 비율 차이 국가
38.12 214.53%
US
30.79 154.06%
US
73.73 508.40%
US
22.25 83.59%
CH
114.95 848.58%
US
P/E 비율 읽는 방법

P/E 비율은 회사의 주가와 주당순이익 간의 관계를 측정합니다.
낮지만 양수인 P/E는 현재 가치 대비 높은 수익을 내고 있는 저평가된 기업을 의미합니다. 높은 음수(0에 가까운) P/E는 큰 손실을 나타냅니다.

P/E가 30을 초과하거나 음수인 기업은 일반적으로 '성장주'로 간주되며, 투자자들은 향후 수익성 개선을 기대합니다.

양의 P/E가 10 미만인 기업은 일반적으로 '가치주'로 간주되며, 이미 매우 수익성이 높고 향후 큰 성장은 기대되지 않습니다.